Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Venrock Associates
Biotech
Amunix scores $117M to fuel T-cell engagers, cytokines
Exactly one year after Amunix raised $73 million, the tech-licensing company turned cancer biotech is drawing another $117 million from the VC well.
Amirah Al Idrus
Mar 4, 2021 9:30am
Federation Bio goes live $50M to pursue microbial treatments
Oct 6, 2020 7:30am
10x Genomics' IPO rockets past a $390M raise
Sep 13, 2019 10:55am
Encoded Therapeutics bags $104M to propel Dravet gene therapy
Jun 26, 2019 9:00am
Unity files for $85M IPO to take anti-aging drugs into phase 1
Apr 6, 2018 8:53am
Anti-aging outfit Unity bags $55M and looks to the clinic
Mar 20, 2018 9:55am
